...
首页> 外文期刊>Japanese Journal of Pharmacology >EXPERIMENTAL ANTICANCER STUDIES
【24h】

EXPERIMENTAL ANTICANCER STUDIES

机译:实验抗癌研究

获取原文

摘要

References(13) Cited-By(1) It was demonstrated by Koshimura et al. in 1955 that Ehrlich ascites carcinoma cells, in phosphate-buffered Ringer's solution, kept for a short time at 37°C in contact with well washed living virulent hemolytic streptococci (Sv) no longer possessed of the power of invading mice (1). In their experiment, the mice were treated with penicillin, so that the animal survived the infection. Soon after, it was also observed that a significant quantity of streptolysin-S was produced in the medium of this kind of experiment (2)—an observation suggesting occurrence of interaction between living hemolytic streptococcus and ribonucleic acid contained in carcinoma cells (3). Any way, this is the beginning of the anticancer experiments now being developed in our laboratories (3). The principal results obtained up to the present are as follows : 1) In contrast with living hemolytic streptococci, heat-killed cocci were ineffective to suppress the invasion power of the tumor cells (1). 2) The anticancer activity appears to be specific for β-hemolytic streptococci, and seems to be not shared by other gram-positive and gram-negative bacteria (6). 3) Supernatant of culture fluid of hemolytic streptococcus, purified streptolysin-S sample, desoxyribonuclease, varidase [DNase+streptokinase (or fibrinolysin)], pancreatic ribonuclease, hyaluronidase, all were also tested to be entirely ineffective in this respect (3, 7). 4) A nearly avirulent-mutant strain of hemolytic streptococci was as effective as its virulent-mother strain (Sv) in depriving the invasion power of carcinoma cells to mice (8). 5) Intratumoral injection of living hemolytic streptococci caused destruction of solid tumor of Ehrlich carcinoma cells in mice (9). 6) Yoshida sarcoma, Sarcoma 180 and leukemia SN 36 cells were also affected by hemolytic streptococci (10). 7) Cell-free extract, prepared under strictly controlled conditions from hemolytic streptococci, was effective in causing the loss of invasion power of Ehrlich carcinoma cell (as well as in synthetizing streptolysin-S in the simple medium containing yeast ribonucleate) (11). Moreover, it should here be added following two experimental results: a) Jordan and his associates have recently made an observation that infection with group A hemolytic streptococci was effective in causing massive degeneration and necrosis of leukemic tumor in mice (12). b) Christensen and Kjems have reported that both living hemolytic streptococci and the phage-lysate of the cocci were inhibitory against Brown-Pearce carcinoma in rabbits (13). The purpose of the present work was to obtain some lights on the question whether or not the anticancer effect of hemolytic streptococci could be expected in immunized animals to the cocci.
机译:参考文献(13)Cited-By(1)Koshimura等人证明了这一点。 1955年,在磷酸盐缓冲的林格氏液中,Ehrlich腹水癌细胞在37°C下短时间保持与经过充分冲洗的活泼的有毒溶血性链球菌(Sv)的接触不再具有侵袭小鼠的能力(1)。在他们的实验中,小鼠接受了青霉素治疗,因此该动物在感染后幸存了下来。此后不久,还观察到在这种实验的培养基中产生了大量的链球菌溶血素-S(2),这一发现表明活血溶血性链球菌与癌细胞中所含核糖核酸之间发生相互作用(3)。无论如何,这是我们实验室目前正在开展的抗癌实验的开始(3)。迄今为止获得的主要结果如下:1)与活血溶血链球菌相比,热灭活的球菌不能有效地抑制肿瘤细胞的侵袭力(1)。 2)抗癌活性似乎对β-溶血性链球菌具有特异性,似乎不与其他革兰氏阳性和革兰氏阴性细菌共有(6)。 3)溶血性链球菌培养液,纯化的链球菌溶血素-S样品,脱氧核糖核酸酶,变异酶[DNase +链激酶(或纤维蛋白溶素)],胰腺核糖核酸酶,透明质酸酶的上清液,在这方面也都被证明完全无效(3,7) 。 4)几乎无毒突变的溶血链球菌菌株在剥夺癌细胞对小鼠的侵袭能力方面与它的强毒母亲菌株(Sv)一样有效(8)。 5)活体内溶血性链球菌瘤内注射引起小鼠艾氏癌细胞实体瘤的破坏(9)。 6)吉田肉瘤,肉瘤180和白血病SN 36细胞也受到溶血链球菌的影响(10)。 7)在严格控制的条件下从溶血性链球菌制备的无细胞提取物可有效导致Ehrlich癌细胞的侵袭力丧失(以及在含有酵母核糖核酸的简单培养基中合成链球菌溶血素S)(11)。此外,应在以下两个实验结果中添加:a)乔丹及其同事最近观察到,A组溶血性链球菌感染可有效导致小鼠大规模变性和白血病肿瘤坏死(12)。 b)Christensen和Kjems报道活的溶血性链球菌和球菌的噬菌体裂解物均能抑制兔的棕熊癌(13)。本工作的目的是就是否可以预期在免疫动物中对球菌的溶血链球菌具有抗癌作用的问题有所了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号